company
Ajanta Pharma USA Inc
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-07-01Ajanta Pharma USA Inc — Class II recall: Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta…
- fda_recall · drug_recall2026-06-24Ajanta Pharma USA Inc — Class II recall: Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma…
Frequently asked questions
- How many FDA warning letters has Ajanta Pharma USA Inc received?
- Argus HQ has not recorded an FDA warning letter for Ajanta Pharma USA Inc in our current dataset.
- What FDA recalls has Ajanta Pharma USA Inc issued?
- Argus HQ has recorded 2 FDA recalls tied to Ajanta Pharma USA Inc.
- Is Ajanta Pharma USA Inc FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 2 recalls, and 0 approval records for Ajanta Pharma USA Inc. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

